Pro Medicus Ltd (PME) - The share price of Pro Medicus Ltd has increased by 22.5% since the beginning of 2025 [1] - Pro Medicus specializes in radiology software, providing solutions such as Radiology Information Systems (RIS), Picture Archiving and Communication Systems (PACS), and advanced visualization tools [2] - The flagship product, Visage software, enables radiologists to remotely view large image files on mobile devices, facilitating on-the-go diagnostic decisions [3] - Currently, Pro Medicus Ltd has a price-sales ratio of 200.05x, significantly higher than its 5-year average of 82.69x, indicating that shares are trading above historical averages despite revenue growth over the last three years [6] James Hardie Industries plc (JHX) - James Hardie Industries is the largest global producer of fiber cement and gypsum products, operating in North America, Europe, Australia, and New Zealand with over 5,200 employees [4] - The main advantages of fiber cement products include fire resistance, water and termite damage resistance, durability, and low maintenance requirements [4] - JHX shares currently trade at a price-sales ratio of 1.79x, which is lower than its 5-year average of 4.14x, suggesting that shares are undervalued compared to historical performance [7]

BHP Group - BHP Group is a diversified natural resources company founded in 1885, focusing on mineral exploration and production, with key areas including copper, iron ore, and coal [1][2] - The company is also diversifying into other sectors such as fertilizers, which indicates a strategic expansion beyond its traditional commodities [2] - BHP shares are considered a reliable dividend-paying investment, commonly included in Australian share portfolios, and are one of the largest companies in Australia [3] BHP Share Price and Dividend Yield - BHP's share price has increased by 1.0% since the beginning of 2025, but the current dividend yield is around 5.42%, lower than its 5-year average of 6.86%, suggesting a potential decline in dividends or an increase in share price [1][6] - The dividend yield reflects the cash flow to shareholders, which can fluctuate, and last year's dividend was less than the 3-year average, indicating a downward trend [6] QBE Insurance Group - QBE Insurance Group started as a marine insurance company in the late 1800s and has grown to become one of Australia's largest insurers, operating in 27 countries and offering a wide range of insurance products [4] - QBE's historical dividend yield is around 4.30%, which is significantly higher than its 5-year average of 2.84%, indicating improved valuation metrics [7] QBE Share Price Valuation - Valuation methods such as Discounted Cash Flow (DCF) and Dividend Discount Models (DDM) are available for investors to assess the value of QBE shares, with resources provided by platforms like Rask [7]

Company Overview - Downer EDI Ltd (ASX: DOW) is a leading provider of integrated infrastructure services in Australia and New Zealand, responsible for building, maintaining, and operating transit systems, utilities services, and public infrastructure [2][3] - The company segments its business into three main areas: Transport (over 50% of revenue), Utilities (around 20%), and Facilities (around 30%) [3] Share Price Performance - DOW share price has increased by 37.7% since the start of 2025, attracting investor interest [1][2] Revenue Stability - A significant portion of DOW's revenue comes from large, multi-year government contracts, providing predictable future revenue despite economic downturns [5] - The company has experienced a compound annual growth rate (CAGR) of -1.6% in revenue over the last three years [6] Dividend Information - DOW currently offers a dividend yield of 2.33%, with an average yield of 3.7% over the past five years, indicating a potential income source for investors [7][10] - The current dividend yield is below its historical average, suggesting that dividends may have fallen or that the share price has increased [10][11] Economic Outlook - Investment in industrial companies like DOW is often viewed as a bet on economic growth, as revenue growth is closely tied to government infrastructure investment and population growth [8]

Company Overview - Transurban Group (ASX:TCL) specializes in managing and developing urban toll road networks across Australia, Canada, and the United States, holding interests in 22 urban motorways including CityLink in Melbourne and the Hills M2 in Sydney [1][2] Financial Performance - TCL's share price has increased by 4.1% since the start of 2025, indicating positive market sentiment [1] - The company has experienced a compound annual growth rate (CAGR) in revenue of 12.6% over the last 3 years, showcasing strong growth potential [6] Dividend Information - Transurban currently offers a dividend yield of 4.43%, which is above its 5-year average of 3.64%, suggesting that the shares are trading at a favorable valuation relative to historical performance [7][10] - The dividend has been growing, as last year's dividend was greater than the 3-year average [11] Industry Context - The S&P/ASX 200 Industrials Index has returned 8.7% over the last 5 years, slightly outperforming the ASX 200 return of 8.5%, highlighting the attractiveness of investing in the industrials sector [3] - Companies in the industrials sector, including TCL, often have reliable revenue streams due to the essential services they provide, which are less sensitive to economic downturns [4][6] Economic Outlook - Investment in industrials companies like TCL is closely tied to economic growth, as revenue growth is linked to government infrastructure investment and population growth [8]

Group 1: Mineral Resources Ltd (MIN) - The share price of Mineral Resources Ltd has increased by 11.9% since the beginning of 2025 and is currently 28.6% above its 52-week lows [1] - Mineral Resources Ltd is a diversified mining company focused on lithium and iron ore extraction in Western Australia, and it also provides mining and engineering services through its subsidiary, CSI Mining Services [1][2] - The company differentiates itself from competitors by maintaining in-house engineering and construction capabilities, allowing for greater control and flexibility during product development [2] Group 2: ResMed (RMD) - ResMed, founded in 1989, specializes in medical equipment, particularly cloud-connectable CPAP machines for treating obstructive sleep apnea, and is headquartered in San Diego, California [3][4] - The company operates in over 140 countries with more than 10,000 employees and has two main business units: Sleep and Respiratory Care, and Software as a Service (SaaS) [4] - In the Sleep and Respiratory Care unit, ResMed provides advanced CPAP machines and ventilation solutions, while the SaaS unit offers software supporting durable medical equipment [4] Group 3: Share Price Valuation - Mineral Resources Ltd currently has a price-to-sales ratio of 1.45x, significantly lower than its 5-year average of 3.02x, indicating that shares may be undervalued or that revenue has increased [6] - ResMed shares are trading at a price-to-sales ratio of 5.70x, which is also below its 5-year average of 8.70x, suggesting a similar undervaluation [7]

Group 1: James Hardie Industries - James Hardie Industries is a building solutions company and the world's largest producer of fibre cement and gypsum products, operating across North America, Europe, Australia, and New Zealand with over 5,200 employees [1] - The share price of James Hardie Industries (ASX:JHX) has decreased by approximately 41.8% since the beginning of 2025 [1] - Currently, James Hardie Industries plc shares have a price-sales ratio of 2.77x, which is lower than its 5-year average of 4.14x, indicating that the shares are trading below historical averages despite revenue growth over the last three years [7] Group 2: CSL Limited - CSL is a global biotechnology company focused on creating and delivering life-saving medicines, with a mission to protect public health and improve the quality of life for individuals with life-threatening conditions [3] - The company operates through three main divisions: CSL Behring, which manufactures blood plasma products; CSL Seqirus, which develops flu-related products; and CSL Vifor, specializing in iron deficiency and nephrology [4] - CSL has established a strong reputation among Australian investors for reliability and consistent dividend payouts, making it a favored choice for those seeking exposure to the growing healthcare sector [5] - CSL is currently paying a trailing dividend yield of around 1.95%, which is higher than its 5-year average of 1.50%, indicating stability and the ability to provide income [8]

Each week we run a DCF (Discounted Cash Flow) model on a company from our watchlist. This week’s pick: Uber Technologies, Inc. (UBER).ProfileUber Technologies Inc. is a global leader in ridesharing and food delivery, operating across more than 70 countries. After years of operating losses, Uber has recently achieved profitability on a net income and free cash flow basis. Its platform benefits from strong network effects, diversified business lines (Mobility, Delivery, Freight), and continued growth in gross ...

Company Overview - Brambles Ltd (ASX: BXB) share price has increased by 30.1% since the beginning of 2025, attracting investor interest [1][2] - The company operates the world's largest pool of reusable pallets, crates, and containers, primarily under the CHEP brand, with a presence in the Asia-Pacific, Americas, and EMEA regions [2] Business Model - Brambles generates revenue through a hiring model, where manufacturers transfer products on CHEP pallets to retailers, and Brambles collects daily hire fees at each step of the supply chain [3] Industry Context - The S&P/ASX 200 Industrials Index has returned 8.4% over the last 5 years, slightly below the ASX 200 return of 8.5%, indicating a stable investment environment for industrials companies like Brambles [4] - Companies in the industrials sector often have reliable revenue streams due to essential services they provide, which can lead to predictable future revenue [5][6] Revenue Growth - Brambles has experienced a compound annual growth rate (CAGR) of 7.6% in revenue over the last 3 years, reflecting its strong market position [6] Dividend Information - Brambles currently offers a dividend yield of 2.02%, with an average yield of 2.7% over the past 5 years, making it an attractive option for income-seeking investors [7][9] - The current dividend yield is below its historical average, suggesting potential for growth in dividends [9][10] Economic Sensitivity - Investment in industrials companies like Brambles is often seen as a bet on economic growth, as revenue is closely tied to government infrastructure investment and population growth [8]

Group 1: Transurban Group (TCL) - Transurban Group's share price has increased by 7.9% since the beginning of 2025 [1] - The company manages and develops urban toll road networks in Australia, Canada, and the United States, with interests in 22 urban motorways [1][2] - Transurban's notable motorways include CityLink in Melbourne, Hills M2 in Sydney, and Logan Motorway in Brisbane [1] Group 2: Financial Performance and Valuation - Transurban has a current dividend yield of approximately 4.28%, which is higher than its 5-year average of 3.64%, indicating potential growth in dividends [5] - The annual report shows that last year's dividend was greater than the 3-year average, suggesting that dividends have been increasing [5] Group 3: Fortescue Ltd (FMG) - Fortescue Ltd is a leading iron ore production and exploration company, shipping over 190 million tonnes annually [3] - The company is expanding its exploration efforts across multiple countries, targeting materials such as copper, rare earths, and lithium [3] - FMG offers a historical dividend yield of around 10.44%, which is comparable to its 5-year average of 10.52% [6]

Company Overview - ResMed is a medical equipment company based in San Diego, California, originally founded in Australia, specializing in cloud-connectable CPAP machines for obstructive sleep apnea treatment [2] - The company operates globally with over 10,000 employees and a presence in more than 140 countries, divided into two primary business units: Sleep and Respiratory Care, and Software as a Service (SaaS) [3] - Netwealth is a wealth management software business that provides a platform for financial planners, with over 140,000 account holders and $88 billion in funds under administration as of 2024 [5] Business Model and Services - ResMed's Sleep and Respiratory Care unit offers industry-leading CPAP machines, catering to a wide range of patients from those needing nightly therapy to those requiring life-support ventilation [3] - The SaaS unit provides software for durable or home medical equipment, enhancing out-of-hospital care [3][4] - Netwealth's platform allows users to manage investments, track performance, and access financial reports through a user-friendly interface [6] Financial Performance and Valuation - ResMed shares have a current price-sales ratio of 5.63x, significantly lower than its 5-year average of 8.70x, indicating potential undervaluation or increased sales [8] - In contrast, Netwealth shares trade at a price-sales ratio of 30.23x, above its 5-year average of 23.72x, suggesting a higher valuation relative to historical performance [9]